This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): TZ-101 , TZ 101
Description: TZ101 is a enzyme-based treatment for use ex vivo in a variety of cell therapies. It is comprised of a recombinant enzyme, a-1,3 fucosyltransferase VI (FTVI), plus its substrate, GDP-fucose. TZ101 is designed to attach a sugar (fucose) to the surface of cells prior to administration of the cells to the patient.
Pink Sheet Weekly Trademark Review Nov. 15, 2011
Pink Sheet Trademark Review
Additional information available to subscribers only: